Lupin Digital Health, a wholly-owned subsidiary of global pharmaceutical giant Lupin Limited, announced the launch of its digital therapeutics solution, LYFE. LYFE is India’s only evidence-based ...

Mumbai: Lupin Digital Health announced the launch of its digital therapeutics solution, LYFE, an evidence-based holistic heart care programme that significantly reduces the risk of a heart attack and ...

An ICMR report states that heart attacks account for 28% of deaths in India. Therefore, the role of digital therapeutics is paramount and should collaborate with the government's mission to address ...

Lupin Digital Health on Tuesday announced the launch of its digital therapeutics solution, LYFE. According to a press statement, LYFE is an evidence-based heart care programme that significantly ...

https://www.thehindubusinessline.com/companies/lupin-collaborates-with-american-college-of-cardiology-to-offer-patients-and-caregivers-at-home-solutions ...

The digital health arm of India-based pharmaceutical company Lupin has unveiled its e-clinic attending to heart failure patients. Called Lyfe, the virtual clinic is manned by a team of paramedics, ...

Lupin Digital Health (LDH), an evidence-based digital therapeutics platform, plans to reach 33 cities in the next three to four months, according to its Chief Executive Officer Sidharth Srinivasan.

Lupin Digital Health, India’s first evidence-based cardiology Digital Therapeutics (DTx) platform, announced that its Lyfe platform has received approval as a Class C Medical Device from the Central ...

Lupin Digital Health, drugmaker Lupin's digital therapeutics arm that focuses on cardiac rehabilitation and care, has doubled its patient base to 10,000 in the past year and expects to grow ...